Friday, May 1, 2026

KAI Opts for Future Tech: Focusing on Reusable Rockets to Keep Pace with SpaceX

Korea Aerospace Industries (047810)(KAI) has decided to focus on developing future technologies, such as reusable rockets...

North Korean Defectors Demand Government Action: 4 Key Requests for POW Recognition

Former POWs urge UN's Elizabeth Salmon to press South Korea on military POW issues, including remembrance and recognition initiatives.

Missile Alert: North Korea’s 600mm Rockets Fly 360 km—What Are the Implications?

North Korea launched several RBMs, presumed to be KN-25 600mm super-large multiple rocket launchers, into the East Sea.

Tag: clinical trials

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

How Samsung Medical Center is Revolutionizing Cancer Patient Care in Asia with EORTC Partnership

Samsung Medical Center's Cancer Hospital partners with EORTC to enhance cancer patients' quality of life through patient-reported outcomes.

Hyundai Bioscience Launches Global Clinical Trials for Dengue Treatment in Vietnam

Hyundai BioScience launches global clinical trials for a broad-spectrum antiviral treatment targeting dengue fever in Vietnam.

Emocog’s Cogthera is Revolutionizing MCI Treatment in 2026

Emocog develops innovative digital therapeutics for mild cognitive impairment, enhancing dementia care through early intervention and AI technology.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

HLB BioStep Signs Strategic MOU with CLIPS BnC… Toward Integrated Preclinical and Clinical Development

HLB BioStep and CLIPS BnC sign MOU to enhance collaboration between preclinical and clinical stages of drug development.

An AI Endoscope Built in Korea: Lighter Controls, Custom Alerts, and a Push Into the U.S. Next

Meditech is revolutionizing endoscopic surgery with AI-driven devices, enhancing diagnosis and treatment while securing significant investments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.